News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
534,526 Results
Type
Article (36103)
Company Profile (235)
Press Release (498188)
Multimedia
Podcasts (69)
Webinars (8)
Section
Business (151265)
Career Advice (817)
Deals (26088)
Drug Delivery (67)
Drug Development (67067)
Employer Resources (69)
FDA (12639)
Job Trends (11115)
News (257389)
Policy (20370)
Tag
Academia (2072)
Academic (1)
Accelerated approval (5)
Adcomms (19)
Allergies (61)
Alliances (43574)
ALS (72)
Alzheimer's disease (1191)
Antibody-drug conjugate (ADC) (159)
Approvals (12659)
Artificial intelligence (288)
Autoimmune disease (23)
Automation (13)
Bankruptcy (199)
Best Places to Work (9438)
BIOSECURE Act (14)
Biosimilars (72)
Biotechnology (192)
Bladder cancer (85)
Brain cancer (30)
Breast cancer (315)
Cancer (2465)
Cardiovascular disease (151)
Career advice (695)
Career pathing (15)
CAR-T (165)
Cell therapy (442)
Cervical cancer (22)
Clinical research (54232)
Collaboration (851)
Company closure (2)
Compensation (379)
Complete response letters (15)
COVID-19 (1776)
CRISPR (47)
C-suite (218)
Cystic fibrosis (83)
Data (2116)
Decentralized trials (2)
Denatured (20)
Depression (30)
Diabetes (199)
Diagnostics (6083)
Digital health (16)
Diversity (6)
Diversity, equity & inclusion (13)
Drug discovery (117)
Drug pricing (58)
Drug shortages (8)
Duchenne muscular dystrophy (67)
Earnings (56923)
Editorial (17)
Employer branding (10)
Employer resources (62)
Events (83203)
Executive appointments (636)
FDA (13818)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (6)
Funding (725)
Gene editing (116)
Generative AI (27)
Gene therapy (278)
GLP-1 (516)
Government (2469)
Grass and pollen (2)
Guidances (124)
Healthcare (14573)
Huntington's disease (18)
IgA nephropathy (26)
Immunology and inflammation (121)
Indications (24)
Infectious disease (1897)
Inflammatory bowel disease (138)
Inflation Reduction Act (7)
Influenza (43)
Intellectual property (95)
Interviews (104)
IPO (12498)
IRA (23)
Job creations (2103)
Job search strategy (593)
Kidney cancer (11)
Labor market (12)
Layoffs (305)
Leadership (9)
Legal (3876)
Liver cancer (82)
Lung cancer (349)
Lymphoma (158)
Machine learning (8)
Management (26)
Manufacturing (254)
MASH (63)
Medical device (12077)
Medtech (12082)
Mergers & acquisitions (14142)
Metabolic disorders (524)
Multiple sclerosis (69)
NASH (14)
Neurodegenerative disease (74)
Neuropsychiatric disorders (18)
Neuroscience (1632)
NextGen: Class of 2025 (4817)
Non-profit (2935)
Now hiring (14)
Obesity (251)
Opinion (163)
Ovarian cancer (83)
Pain (87)
Pancreatic cancer (91)
Parkinson's disease (130)
Partnered (16)
Patents (222)
Patient recruitment (106)
Peanut (34)
People (43666)
Pharmaceutical (38)
Pharmacy benefit managers (11)
Phase I (18639)
Phase II (24158)
Phase III (16795)
Pipeline (1244)
Policy (82)
Postmarket research (1588)
Preclinical (7983)
Press Release (67)
Prostate cancer (114)
Psychedelics (16)
Radiopharmaceuticals (260)
Rare diseases (318)
Real estate (4067)
Recruiting (28)
Regulatory (15692)
Reports (21)
Research institute (2079)
Resumes & cover letters (164)
Rett syndrome (5)
RNA editing (5)
RSV (35)
Schizophrenia (52)
Series A (133)
Series B (80)
Service/supplier (7)
Sickle cell disease (44)
Special edition (8)
Spinal muscular atrophy (113)
Sponsored (25)
Startups (3132)
State (2)
Stomach cancer (16)
Supply chain (39)
Tariffs (21)
The Weekly (47)
Vaccines (515)
Venture capitalists (29)
Weight loss (139)
Women's health (23)
Worklife (5)
Date
Last 7 days (805)
Last 30 days (2542)
Last 365 days (28165)
2025 (10161)
2024 (30690)
2023 (34929)
2022 (44744)
2021 (47427)
2020 (43736)
2019 (36226)
2018 (27036)
2017 (26697)
2016 (25142)
2015 (29202)
2014 (22004)
2013 (18152)
2012 (19443)
2011 (19765)
2010 (18348)
Location
Africa (445)
Alabama (50)
Alaska (6)
Arizona (158)
Arkansas (13)
Asia (33273)
Australia (5864)
California (5616)
Canada (1630)
China (498)
Colorado (231)
Connecticut (251)
Delaware (132)
Europe (73230)
Florida (813)
Georgia (193)
Idaho (42)
Illinois (436)
India (22)
Indiana (293)
Iowa (7)
Japan (164)
Kansas (96)
Kentucky (21)
Louisiana (8)
Maine (51)
Maryland (756)
Massachusetts (4147)
Michigan (207)
Minnesota (328)
Mississippi (2)
Missouri (80)
Montana (25)
Nebraska (15)
Nevada (38)
New Hampshire (68)
New Jersey (1479)
New Mexico (26)
New York (1580)
North Carolina (817)
North Dakota (8)
Northern California (2458)
Ohio (161)
Oklahoma (12)
Oregon (35)
Pennsylvania (1133)
Puerto Rico (12)
Rhode Island (29)
South America (661)
South Carolina (24)
South Dakota (1)
Southern California (2148)
Tennessee (78)
Texas (862)
United States (20563)
Utah (159)
Virginia (129)
Washington D.C. (27)
Washington State (512)
West Virginia (3)
Wisconsin (56)
534,526 Results for "cancer targeted technology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cancer
Perioperative Keytruda Cuts Risk of Negative Events by Over 25% in Head and Neck Cancer
The FDA is currently reviewing Merck’s sBLA for Keytruda in head and neck cancer, with a target action date of June 23.
April 28, 2025
·
1 min read
·
Tristan Manalac
Bladder cancer
J&J Declares ‘Sustained Disease Control’ With Bladder Cancer Drug-Device Combo
The targeted drug release device TAR-200 shows promising response and disease-free survival rates in specific populations of patients with non-muscle-invasive bladder cancer.
April 28, 2025
·
2 min read
·
Tristan Manalac
Press Releases
ViVerita Therapeutics Announces Research Collaboration with Boehringer Ingelheim to Accelerate Discovery of Novel Cancer Targets
May 7, 2025
·
2 min read
Press Releases
Pilatus Biosciences Publishes Preclinical Data in Cancer Discovery on PLT012 First-in-Class CD36-Targeting Antibody for Liver Cancer
April 30, 2025
·
4 min read
Press Releases
Targeting TROP2 As Next Generation Cancer Treatment Innovation
March 19, 2025
·
1 min read
Press Releases
BriaCell’s Subsidiary, BriaPro, Develops Novel Antibodies to Anti-Cancer Target B7-H3
April 10, 2025
·
5 min read
Press Releases
City of Hope Study Demonstrates Proof of Concept for Targeted New Approach to Treat Pancreatic Cancer
April 8, 2025
·
5 min read
Press Releases
UTR Therapeutics Inc Announces IND submission to the US FDA for a First-in-Human Clinical Trial of an mRNA destabilizing drug targeting c-MYC driven cancers
May 9, 2025
·
3 min read
Press Releases
Data from First-in-Human Trial targeting CISH, a Novel Immune Checkpoint, in Patients with Metastatic Colorectal Cancer Presented at 2025 American Association for Cancer Research (AACR) Annual Meeting
May 2, 2025
·
5 min read
Press Releases
Integrated DNA Technologies Introduces Transformative Hybridization Capture Solution to Accelerate Cancer Research
April 21, 2025
·
3 min read
1 of 53,453
Next
